2022
medRxiv (2022). 10.1101/2022.04.16.22273762.
2022
European Respiratory Journal, (2022).59 4 10.1183/13993003.00166-2022.
2022
EBioMedicine, (2022).79, 10.1016/j.ebiom.2022.103993.
Cost-effectiveness of shortened regimens for DR-TB.
2022
(2022).
2022
BMC INFECTIOUS DISEASES, (2022).22 1 10.1186/s12879-022-07339-w.
2022
European Journal of Immunology, (2022).52 7 10.1002/eji.202249815.
2022
Gates Open Research, (2022).5, 10.12688/gatesopenres.13191.2.
2022
BMJ global health, (2022).7 4 10.1136/bmjgh-2021-007136.
2022
Communications Biology, (2022).5 1 10.1038/s42003-022-03194-2.
